Frank DeBenedittis - Aceto Insider

Aceto Corporation -- USA Stock  

USD 7.11  0.10  1.39%

Sr. VP of Corporate Bus. Devel. and International Sr. VP of Active Pharmaceutical Ingredients

Mr. Frank V. DeBenedittis is Senior Vice President Corporationrationrate Business Development of Aceto Corporationration He has served as Senior Vice President, Corporationrationrate Business Development since August 2011 and International Senior Vice President, Active Pharmaceutical Ingredients since February 2011. Prior to that, Mr. DeBenedittis was Executive Vice President since January 2009 and Senior Vice President of the Company since 2001. Mr. DeBenedittis joined the Company in 1979 as a marketing assistant and held various positions within the Company including Assistant Product Manager, Product Manager, Assistant Vice President and Vice President. In addition, Mr. DeBenedittis currently serves on the board of directors of Rising Pharmaceuticals, Inc., a wholly owned subsidiary of the Company
Age: 60  SVP Since 2011      
DeBenedittis holds a B.A. in Chemistry from Stony Brook University.

Management Efficiency

The company has return on total asset (ROA) of 2.45 % which means that it generated profit of $2.45 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (1.48) % meaning that it created substantial loss on money invested by shareholders.
The company currently holds 326.5 M in liabilities with Debt to Equity (D/E) ratio of 82.2 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Aceto Corporation has Current Ratio of 1.96 which is within standard range for the sector.

Similar Executives

Found 6 records

SVP Since

Darin TangVeritiv Corporation
Thomas LazzaroVeritiv Corporation
Kent YeeDXP Enterprises Inc
Todd HamlinDXP Enterprises Inc
Loriann SheltonVOXX International Corporation
Joseph MyersVeritiv Corporation

Entity Summary

Aceto Corporation, together with its subsidiaries, sources, markets, sells, and distributes finished dosage form generics, nutraceutical products, pharmaceutical intermediates and active ingredients, agricultural protection products, and specialty chemicals. Aceto Corporation was founded in 1947 and is headquartered in Port Washington, New York. Aceto operates under Chemicals - Major Diversified classification in USA and traded on NASDAQ exchange. It employs 286 people.Aceto Corporation (ACET) is traded on NASDAQ in USA. It is located in NEW YORK, U.S.A and employs 286 people. Aceto is listed under Wholesale category by Fama And French industry classification.

Did you try this?

Run Analyst Recommendations Now

Analyst Recommendations

Analyst recommendations and target price estimates broken down by several categories
Hide  View All  NextLaunch Analyst Recommendations
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Aceto Corporation to your portfolio

Top Management

Aceto Leadership Team
Hans Noetzli, Director
Frank DeBenedittis, SVP
Douglas Roth, CFO, MBA
Natasha Giordano, Director
Richard Randall, Director
Alan Levin, Director
Daniel Yarosh, Director, Ph.D
Carlos Restrepo, President
Vimal Kavuru, President
Nicholas Shackley, President
Salvatore Guccione, CEO
Steven Rogers, SVP
Albert Eilender, Chairman
Walter Kaczmarek, COO
Jody Burfening, Executive
William Kennally, Director
Charles Alaimo, President
William Britton, Director
Terry Kippley, President, MBA
Fran Scally, Executive
Satish Srinivasan, President, MBA
Raymond Bartone, President

Stock Performance

Aceto Performance Indicators